In Vivo Contract Research Organization Market Report 2026

In Vivo Contract Research Organization Market Overview

• In Vivo Contract Research Organization market size has reached to $5.23 billion in 2025 • Expected to grow to $7.77 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Rising Focus on Personalized Medicine Fueling the Growth Of The Market Due To Increasing Demand For Tailored Preclinical Studies • Market Trend: Accelerating Innovation In Early-Stage Therapeutics Through Advanced Incubator Initiatives • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under In Vivo Contract Research Organization Market?

In vivo contract research organization refers to a specialized service provider that conducts research and testing involving live animals to evaluate the safety, efficacy, and pharmacological effects of drug candidates or medical devices before clinical trials in humans. These organizations play a critical role in preclinical development by offering services such as toxicology, pharmacokinetics, and disease modeling using rodent and non-rodent models. The main types of in vivo contract research organizations are rodent-based and non-rodent-based. Rodent-based refers to preclinical research or testing conducted using rodents, such as mice or rats, as model organisms to study the safety, efficacy, and biological effects of new drugs or therapies before human trials. The services offered are typically clinical trial services, preclinical services, and post-market services. These organizations operate under different laboratory standards, including good laboratory practice toxicology and non-good laboratory practice. Their research supports a wide range of applications, such as oncology, cardiovascular diseases, infectious diseases, neurological disorders, and others. Cater to various end users, including pharmaceutical companies, biotechnology companies, contract research organizations (CROs), academic and research institutes, and government and regulatory bodies.

What Is The In Vivo Contract Research Organization Market Growth Forecast?

The in vivo contract research organization market size is expected to see strong growth in the next few years. It will grow to $7.77 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for faster drug development timelines, rising use of advanced in vivo disease models, expansion of oncology and rare disease research, growing adoption of ai-enabled preclinical analytics, increasing regulatory scrutiny of safety data. Major trends in the forecast period include increasing outsourcing of preclinical research activities, rising demand for specialized disease models, growing adoption of glp-compliant toxicology studies, expansion of integrated preclinical service offerings, enhanced focus on data quality and reproducibility.

Global In Vivo Contract Research Organization Market Segmentation

1) By Type: Rodent Based, Non-Rodent Based 2) By Type Of Service: Translational And IND-Enabling In Vivo Studies, Preclinical Services, Post-Approval Nonclinical Safety And Mechanistic Studies 3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice 4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications 5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies Subsegments: 1) By Rodent-Based: Mice Models, Rat Models, Genetically Engineered Rodents, Immunodeficient Rodents, Humanized Rodents 2) By Non-Rodent-Based: Canine Models, Non-Human Primate Models, Swine Models, Rabbit Models, Zebrafish Models

What Is The Driver Of The In Vivo Contract Research Organization Market?

The growing focus on personalized medicine is expected to propel the growth of the in vivo contract research organization market going forward. Personalized medicine is a medical approach that tailors treatment and prevention strategies to an individual's genetic makeup, lifestyle, and environment to optimize health outcomes. The growing focus on personalized medicine is due to increasing accessibility and affordability of genomic sequencing technologies, as these advancements allow for more accurate identification of genetic mutations, enabling tailored therapies that improve patient outcomes and reduce trial-and-error in treatment. The growing focus on personalized medicine is driving demand in the in vivo CRO market, as customized preclinical studies using specific animal models are needed to evaluate targeted therapies and their effects on distinct genetic profiles. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the FDA approved 16 new personalized treatments in 2023, up from six in 2022. Personalized medicines accounted for more than one-third of all new drug approvals by the U.S. Food and Drug Administration (FDA) for the fourth consecutive year. Therefore, the growing focus on personalized medicine is driving the growth of the in vivo contract research organization industry.

Key Players In The Global In Vivo Contract Research Organization Market

Major companies operating in the in vivo contract research organization market are Thermo Fisher Scientific Inc, Labcorp Drug Development Inc, Eurofins Scientific SE, WuXi AppTec, Charles River Laboratories International Inc, Evotec SE, GemPharmatech Co Ltd, BIOQUAL Inc, Crown Bioscience Inc, PsychoGenics Inc, Janvier Labs SAS, Taconic Bioscience Inc, Xentech SAS, Altogen Labs Inc, AniLocus Inc, Pharmaron Beijing Co Ltd, Southern Research Institute, SRI International, Envigo RMS LLC, Horizon Discovery Group plc, Inotiv Inc, GenScript ProBio

Global In Vivo Contract Research Organization Market Trends and Insights

Major companies operating in the in vivo contract research organization market are focusing on developing innovative solutions, such as advanced therapy incubator programs, to accelerate the development of next-generation therapeutics and support early-stage clinical research. An advanced therapy incubator program is a specialized initiative designed to support early-stage biotechnology companies by providing resources, mentorship, and infrastructure to accelerate the development of advanced therapies such as gene, cell, and RNA-based treatments. For instance, in April 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, launched its inaugural advanced therapy incubator program cohort. This innovative initiative is designed to support early-stage biotech companies focused on developing next-generation therapies. Through the program, participants gain access to Charles River’s scientific expertise, state-of-the-art laboratory infrastructure, and customized in vivo models, enabling them to rapidly generate proof-of-concept data. The program also provides a real-world preclinical setting for validating therapeutic candidates, helping to shorten time-to-clinic and improve the likelihood of regulatory success. By bridging the gap between academic innovation and clinical development, the initiative plays a crucial role in advancing the field of advanced therapies.

What Are Latest Mergers And Acquisitions In The In Vivo Contract Research Organization Market?

In September 2024, PharmaLegacy Laboratories Co. Ltd., a China-based preclinical contract research organization (CRO) specializing in pharmacology, acquired BTS Research for an undisclosed amount. With the acquisition, PharmaLegacy Laboratories aims to strengthen its preclinical service offerings and establish a strategic laboratory presence in North America to better support global biopharmaceutical clients. BTS Research Inc. is a US-based biotech company that offers both in vitro and in vivo programs.

Regional Outlook

North America was the largest region in the in vivo contract research organization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the In Vivo Contract Research Organization Market?

The in vivo contract research organization market includes revenues earned by entities by providing services such as conducting pharmacokinetic studies, toxicology testing, and efficacy studies, and related services such as animal modeling, biomarker analysis, and data interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the In Vivo Contract Research Organization Market Report 2026?

The in vivo contract research organization market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the in vivo contract research organization industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.